Int J Mol Sci January 2023 PMID 36768785

Microbiome Alterations in Alcohol Use Disorder and Alcoholic Liver Disease.

Kamil Litwinowicz, Andrzej Gamian

Full text PDF Download social card

Mentions

Peak: 2 in Sep 2025

across 2 sources since Jan 2023

Extended reach

1,119,940

potential audience

Total likes

22,415

Video views

1,114,128

Mentions per month

Jan 2023 – Nov 2025

Where it's discussed

YouTube7 videos
X / Twitter2 posts

AI synopsis

What people are saying

The discussions consistently highlight the importance of microbiome alterations in the progression of alcohol-related liver disease, using words like 'significant' and 'crucial.' The tone reflects curiosity and optimism about future implications, demonstrated by phrases such as 'bioinformatics advances improve understanding' and 'potential for new treatments,' which emphasize the perceived importance of the research findings.

AgreementModerate agreement

Most discussions acknowledge the significance of microbiome changes in AUD and ALD, with some calling the findings 'groundbreaking' or 'very relevant,' indicating general support.

InterestHigh interest

Participants show high interest, referencing specific microbes affected, such as butyrate producers and endotoxin producers, and discussing bioinformatics advances, which reflect enthusiasm and curiosity.

EngagementModerate engagement

The discussions involve some multiple references to methods and potential implications, but mostly remain at a surface level of interest without deep technical analysis.

ImpactModerate impact

Users believe the research could influence future therapy approaches or understanding of liver diseases, though the discussions lack concrete proposals or direct policy implications, reflecting moderate perceived impact.

Abstract in brief

Microbiome changes play a crucial role in alcohol use disorder (AUD) and alcoholic liver disease (ALD) development.
Recent bioinformatics advances allow for detailed study of these changes, enhancing our understanding of their impact.
In the study involving 122 AUD patients, 75 ALD patients, 54 with non-alcoholic liver diseases, and 260 healthy controls, researchers found significant decreases in beneficial butyrate-producing microbes and increases in harmful endotoxin-producing microbes linked to AUD and ALD progression.

Read the full abstract